English | 简体中文 | 繁體中文 | 한국어
 All Press Releases

牧原股份港股上市:全球生豬养殖龍頭 價值成長兼具
Feb 06, 2026 15:08 HKT
牧原股份港股上市:全球生猪养殖龙头 价值成长兼具
Feb 06, 2026 15:01 HKT
優異供應鏈賦能與國際化佈局雙輪驅動 綠茶開啟高質量成長新篇章
Feb 06, 2026 14:47 HKT
优异供应链赋能与国际化布局双轮驱动 绿茶开启高质量成长新篇章
Feb 06, 2026 14:33 HKT
Everest Medicines Announces China NMPA Approval of VELSIPITY(R) for Adults with Moderately to Severely Active Ulcerative Colitis
Feb 06, 2026 14:17 HKT
雲頂新耀維適平(R)獲中國國家藥品監督管理局批准上市 為中重度潰瘍性結腸炎治療提供新選擇
Feb 06, 2026 14:11 HKT
云顶新耀维适平(R)获中国国家药品监督管理局批准上市 为中重度溃疡性结肠炎治疗提供新选择
Feb 06, 2026 14:03 HKT
Spritzer Celebrates Continued Excellence with Dual Recognition at Putra Brand Awards 2025 and Superior Taste Award 2025
Feb 06, 2026 13:13 HKT
「工業數智化引擎」卡奧斯衝擊港交所 激活製造業新动能
Feb 06, 2026 12:45 HKT
「工业数智化引擎」卡奥斯冲击港交所 激活制造业新动能
Feb 06, 2026 12:38 HKT
Mitsubishi Motors Launches the All-New Versa Van in the Philippine Market
Feb 06, 2026 12:34 HKT
Eternal Beauty Holdings Limited and Lane Crawford Debut Landmark Fragrance, Further Expanding Footprint in High-Margin Niche Fragrance Market
Feb 06, 2026 12:21 HKT
穎通控股與連卡佛攜手打造首個頂級小眾香水殿堂 進一步拓展高毛利小眾香氛市場版圖
Feb 06, 2026 12:07 HKT
颖通控股与连卡佛携手打造首个顶级小众香水殿堂 进一步拓展高毛利小众香氛市场版图
Feb 06, 2026 11:53 HKT
Distinct Healthcare Successfully Listed on HKEX, Bolstered by Premium Customer Base and All-Star Cornerstone Investors
Feb 06, 2026 11:44 HKT
中國再保召開2026年黨建和經營管理工作會議
Feb 06, 2026 11:04 HKT
2月24日-2月27日、世界の金融リーダーが集結する国際フォーラム「GFTN Forum Japan 2026」開催
Feb 06, 2026 11:00 HKT
2月24日-2月27日、世界の金融リーダーが集結する国際フォーラム「GFTN Forum Japan 2026」開催
Feb 06, 2026 11:00 HKT
Establishment of the World's First*1 Global Supply Chain to Introduce the Use of Renewable Plastics in Sony's High-Performance Products
Feb 06, 2026 10:50 HKT
Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan
Feb 06, 2026 10:31 HKT
<< Previous Next >>
 Releases By Language
All
English
Indonesian
Japanese
Korean
Thai
Trad. Chinese
Simp. Chinese
Vietnamese
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: